Side-by-side comparison of AI visibility scores, market position, and capabilities
AMS: HEIA second-largest global brewer at €30.3B FY2024 revenue with Heineken, Amstel, Dos Equis, and Tiger Beer across 190+ countries; Heineken 0.0 and Silver growth competing with AB InBev and Carlsberg for premium and no-alcohol beer.
Heineken N.V. is an Amsterdam, Netherlands-based global brewing company — listed on Euronext Amsterdam (AMS: HEIA) — operating the world's second-largest brewing company (by volume, behind AB InBev) with a portfolio of 300+ beer brands including Heineken (the flagship international lager), Amstel, Dos Equis, Tecate, Sol, Tiger Beer, Red Stripe, Birra Moretti, and 180+ regional and local brands distributed in 190+ countries through owned breweries, licensed brewing partners, and distribution partnerships. Heineken generated €30.3 billion in consolidated revenue in fiscal year 2024 (+2.1% organically) with 85,000+ employees across 70+ countries and 165 breweries — the product of a century of international acquisition and organic growth that transformed the 1873-founded Amsterdam brewer into the second-largest beer company globally.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.